| Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value L Marisa, A de Reyniès, A Duval, J Selves, MP Gaub, L Vescovo, ... PLoS medicine 10 (5), e1001453, 2013 | 1424 | 2013 |
| Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and … T André, A De Gramont, D Vernerey, B Chibaudel, F Bonnetain, ... Journal of Clinical Oncology 33 (35), 4176-4187, 2015 | 761 | 2015 |
| Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR N Suraweera, A Duval, M Reperant, C Vaury, D Furlan, K Leroy, R Seruca, ... Gastroenterology 123 (6), 1804-1811, 2002 | 717 | 2002 |
| Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability A Duval, R Hamelin Cancer research 62 (9), 2447-2454, 2002 | 543 | 2002 |
| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 535 | 2020 |
| The prevalence of PIK3CA mutations in gastric and colon cancer S Velho, C Oliveira, A Ferreira, AC Ferreira, G Suriano, S Schwartz Jr, ... European journal of cancer 41 (11), 1649-1654, 2005 | 487 | 2005 |
| Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’(C4CMMRD) K Wimmer, CP Kratz, HFA Vasen, O Caron, C Colas, N Entz-Werle, ... Journal of medical genetics 51 (6), 355-365, 2014 | 474 | 2014 |
| KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ... Oncogene 26 (1), 158-163, 2007 | 291 | 2007 |
| Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors O Buhard, F Cattaneo, YF Wong, SF Yim, E Friedman, JF Flejou, A Duval, ... Journal of clinical oncology 24 (2), 241-251, 2006 | 285 | 2006 |
| Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability A Duval, J Gayet, XP Zhou, B Iacopetta, G Thomas, R Hamelin Cancer research 59 (17), 4213-4215, 1999 | 280 | 1999 |
| The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines A Duval, S Rolland, E Tubacher, H Bui, G Thomas, R Hamelin Cancer research 60 (14), 3872-3879, 2000 | 254 | 2000 |
| Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency … R Cohen, E Hain, O Buhard, A Guilloux, A Bardier, R Kaci, P Bertheau, ... JAMA oncology 5 (4), 551-555, 2019 | 240 | 2019 |
| Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines J Gayet, XP Zhou, A Duval, S Rolland, JM Hoang, P Cottu, R Hamelin Oncogene 20 (36), 5025-5032, 2001 | 229 | 2001 |
| Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D”(C4CMMR-D) HFA Vasen, Z Ghorbanoghli, F Bourdeaut, O Cabaret, O Caron, A Duval, ... Journal of medical genetics 51 (5), 283-293, 2014 | 214 | 2014 |
| Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis O Buhard, N Suraweera, A Lectard, A Duval, R Hamelin Disease markers 20 (4-5), 251-257, 2004 | 208 | 2004 |
| Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis C Dorard, A De Thonel, A Collura, L Marisa, M Svrcek, A Lagrange, ... Nature medicine 17 (10), 1283-1289, 2011 | 189 | 2011 |
| Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without … A Zaanan, P Cuilliere-Dartigues, A Guilloux, Y Parc, C Louvet, ... Annals of oncology 21 (4), 772-780, 2010 | 180 | 2010 |
| BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency C Oliveira, M Pinto, A Duval, C Brennetot, E Domingo, E Espín, ... Oncogene 22 (57), 9192-9196, 2003 | 178 | 2003 |
| Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study F Pagès, T André, J Taieb, D Vernerey, J Henriques, C Borg, F Marliot, ... Annals of Oncology 31 (7), 921-929, 2020 | 158 | 2020 |
| Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression F Jourdan, N Sebbagh, E Comperat, N Mourra, A Flahault, S Olschwang, ... Virchows Archiv 443, 115-121, 2003 | 154 | 2003 |
Thierry AndréHôpital Saint Antoine在 aphp.fr 的电子邮件经过验证
